BioSpace News Archive

Biotech Bay

GRAIL Grabs $300 Million Ahead of Possible IPO on Hong Kong Exchange

With a new chief executive officer on board, GRAIL, Inc. has secured a whopping $300 million in an oversubscribed Series C financing round led by multiple Chinese investment groups.

May 22, 2018
·
3 min read
·
Alex Keown
Business

Celgene’s Deal Boss Golumbeski Made a Quiet Exit in April

Celgne’s head of business development, George Golumbeski, has also left the company.

May 22, 2018
·
3 min read
·
Mark Terry
Deals

Who are the Top 3 Biotech Takeover Targets?

Most investors thought 2018 would be a big year for mergers and acquisitions in the biopharma industry because of changes to the tax law, and so far they’ve been right.

May 22, 2018
·
3 min read
·
Mark Terry
Business

Allergan Draws on Another Aptinyx Compound to Complement its Phase III Depression Drug

Allergan has exercised an option to acquire an oral small molecule compound from Illinois-based Aptinyx, a spinout of Naurex, Inc., which the Irish company acquired in 2015. The company will use it as a complement to a Phase III depression treatment.

May 22, 2018
·
2 min read
·
Alex Keown
One Last Chance: What to Do Before Quitting Your Job!

Are you fantasizing about quitting your job? It can be difficult to stay focused and productive if you’re in a negative or toxic work environment.

May 22, 2018
·
4 min read
·
Porschia Parker
Business

Biotech CEO’s Wild Stunt and Death Shines Light on Community of Biohackers

The mysterious death of a biotech startup chief executive officer in late April projected the term biohacker into the forefront of the industry lexicon.

May 22, 2018
·
3 min read
·
Alex Keown
BioCapital

Educational Institutions Highlight Biotech Through Partnerships and Programs

Educational institutions, even at the high school level, are creating specialized biotechnology training programs to satisfy the growth they see within the biotech industry.

May 22, 2018
·
2 min read
·
Mark Terry
Deals

Ahead of the Takeda-Shire Takeover, Takeda Selling Chinese Joint Venture

With the acquisition of Dublin-based Shire by Japan-based Takeda Pharmaceutical pretty much a done-deal, Takeda appears to be getting its financial house in order before it closes.

May 22, 2018
·
2 min read
·
Mark Terry